ACI: Plan B Judge to Speak at ACI’s Over the Counter Drugs Forum

NEW YORK - Sept. 9, 2013 - PRLog -- American Conference Institute (ACI) is pleased to announce that The Honorable Edward R. Korman, U.S.D.J., from United States District Court for the Eastern District of New York who issued the landmark decision in Tummino v. Hamburg (the Plan B One Step case) will be a presenter at ACI’s Second Annual Legal, Regulatory and Compliance forum on Over the Counter Drugs which will take place in New York City on October 29-30, 2013.

As Stephanie Butler, Division Manager of ACI’s  Life Sciences and Health Care  Division noted “this conference presents a unique opportunity to not only hear from the FDA, FTC, and leading OTC industry representatives, but also from the very Judge whose decision has altered the OTC legal and regulatory landscape.”

Lisa J. Piccolo, Senior Industry Manager, Life Sciences and Health Care with ACI, stated “ACI is proud and honored to bring the OTC industry the opportunity to hear from Judge Korman on a case which in essence upheld the tenants of the current OTC paradigm of self-diagnosis and self -care and also set the stage for the furtherance of the FDA’s NSURE initiative” Judge Korman’s presence together with that of FDA, FTC, NAD and the legal and regulatory “who’s who” of the OTC industry make this an essential gathering for legal and regulatory representatives for  non-prescription drug manufacturers.  The faculty not only includes the aforementioned key government authorities, but also has representatives from such leading OTC drug makers as Pfizer, Reckitt Benckiser, Novartis Consumer Health, GlaxoSmithKlein Consumer Healthcare, Colgate Palmolive, and Similisan in addition to key food and drug lawyers who specialize in this area of non-prescription drug products.”

Co- Chairs:

·         Melinda Friend, Chief Regulatory Counsel, Colgate Palmolive

·         Diane C. McEnroe, Partner, Sidley Austin

FDA

·         Rikin Mehta, PharmD, JD, LLM, Deputy Director, Division of Medical Policy Programs,United States Food and Drug Administration, CDER, Office of Medical Policy, Office of Medical Policy Initiatives

FTC

·         Nur-ul-Haq, Staff Attorney, Northeast Regional Office, Federal Trade Commission

NAD

·         David G. Mallen, Associate Director, National Advertising Division, Council of Better Business Bureaus

·         Laura Brett, Staff Attorney, National Advertising Division, Council of Better Business Bureaus

Industry

·         Diane E. Furman, Senior Patent Counsel, Novartis Consumer Health, Inc.

·         Todd Halpern, Assistant General Counsel, Regulatory Law, Pfizer Inc.

·         Mark Brian Levine, Associate General Counsel, Reckitt Benckiser LLC

·         Larry Miller, Chief Counsel, Pfizer Consumer Healthcare

·         Kimberly Mills, Director of Regulatory Affairs & Quality Assurance, Similasan Corporation

·         Erin Oliver ,MS, MBA, RAC, Director, Regulatory Affairs, GalaxoSmithKlein Consumer Healthcare

·         Spring C. Potoczak, Associate General Counsel, Novartis Consumer Health, Inc.

·         Renuka Singh, Senior  Counsel, Reckitt Benckiser LLC

·         Marcy Sussman, RAC, Director, Regulatory Affairs, GlaxoSmithKline Consumer Healthcare

·         Thomas Blake, Regulatory Strategist

·         Arnold Burstein, Executive Vice President, BioClara Group

·         Susan B. Levy, Principal, Susan B. Levy Consulting

Law Firm

·         David G. Adams, Partner,  Venable LLP

·         Sharon A. Blinkoff, Counsel,  Edwards Wildman Palmer LLP

·         Dickerson M. Downing, Partner, Crowell & Moring LLP

·         Stacey Ehrlich,  Partner, Kleinfeld, Kaplan and Becker, LLP

·         Christopher G. FitzPatrick,  Partner, Smith, Gambrell & Russell, LLP

·         David M. Fox, Partner, Hogan Lovells

·         Edward F. Glynn, Jr., Partner, Manatt, Phelps & Phillips

·         Paul M. Hyman, Director, Hyman, Phelps  McNamara

·         Robert M. Isackson, Partner, Orrick, Herrington & Sutcliffe LLP

·         James R. Johnson, Attorney, Hogan Lovells

·         Michael s. Labson, Partner, Covington & Burling LLP

·         William A. McConaga, Partner, Sidley Austin LLP

·         Paul D. Rubin,Partner, Ropes & Gray LLP

·         Frederick A. Stearns, Partner,  Keller and Heckman LLP

·         Gary L. Yingling, Partner, Morgan, Lewis & Bockius LLP

·         Jennifer Zachary, Attorney, Covington & Burling LLP

Full information on the forum can be found at www.AmericanConference.com/OTCDrugs

-----------------------------------------------------------------------------------------------------------

A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.

Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.

Headquartered in New York and led by Leigh Gilmore, Senior Vice President, and Scott DeNardo, Managing Director, American Conference Institute has grown to produce more than 220 events each year, attended by thousands of senior delegates from across the country.